This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate. The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess. Here are the biggest S&P Health Care gainers and losers over while the debate has waged on. Read More
Following are the day’s biggest winners and losers. Find out why shares of IMS Health and Lamar Advertising popped while American Eagle and Whole Foods Market dropped. Read More
How should investors be positioning their portfolios for the new week and new month? Alan Valdes, vice president of Kabrik Trading, and Charles Bobrinskoy, vice chairman and director of research at Ariel Investments, shared their insights. Read More
With $137 billion worth of brand name drugs going generic over the next several years, the recession and the looming threat of healthcare reform a lot of people have been running scared about what it all means for pharma. So, surprise, surprise! This morning IMS Health, which closely monitors the industry, came out with its annual forecast and it now says the American drug market is going to grow this year instead of shrink. Read More
Bob Pavlik, chief market strategist at Banyan Partners, and Charles Bobrinskoy, vice chairman and director of research at Ariel Investments, told CNBC how investors can prepare their portfolios for the week ahead. Read More